CEO Roger Susi adopts 10b5-1 plan to sell IRMD shares daily through Dec 2023

IRADIMED CORP

CEO Roger Susi entered into a 10b5-1 plan on Feb 6, 2023 for daily sales of shares starting Feb 13, 2023.
Plan runs until Dec 31, 2023 or earlier completion/termination; subject to minimum price threshold.
Sales will be disclosed via Form 4 filings; purpose is to increase public float in a non-dilutive manner.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.